Get a Free Case Evaluation. No Fee Unless We Win. Call or Text 503-222-6333

Diabetes Drug Actos May Increase Risk of Cancer

Actos a prescription drug of the class thiazolidinedione that is used to treat type 2 diabetes. This week, the FDA announced that patients taking Actos for more than a year may have an increased risk of bladder cancer. The FDA’s announcement is based on its review of data from a planned five-year interim analysis of an ongoing, ten-year epidemiological study.

France and Germany have already banned the drug, although the European Medicines Agency (EMA) has yet to release any guidance on use ofthe drug.

The sale of another drug of the same class, Avandia (Rosiglitazone), was severely restricted last year in the United States because of concerns that it increased the risk of heart attack.

About the <span>Author</span>

About the Author

Tom D'Amore is the founder of D'Amore Law Group and a trial attorney with over 30 years of experience representing injured people and their families across the West Coast, securing more than $325 million in recoveries. He handles cases involving car accidents, trucking accidents, construction injuries, medical malpractice, and sexual abuse. Licensed in Oregon, Washington, and California, Tom is the only NBTA board-certified truck accident attorney in Oregon. He is a national Board of Governors member, past Executive Committee member, and past Budget and Audit Chair of the American Association for Justice, as well as past President of the Oregon Trial Lawyers Association and an Eagle member of the Washington State Association for Justice.
Contact Us
I accept the Terms
I accept the Terms